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Will neuroscience account for the psychotherapeutic 
outcome in schizophrenia?
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Summary
Neuroscientific research explaining the effectiveness of psychotherapy went in three directions. The first, 
basing on a theory of explicit (declarative, conscious) and implicit (procedural, subconscious) memory 
aims at reinterpretation of the mechanisms of psychotherapy. This method is useful in analysing effects 
of cognitive psychotherapy but also psychoanalytically oriented psychotherapy which is based on inter-
pretations and insight. 
The second current in such research is connected with the possibility of neuroimaging, which allows to 
evaluate changes occurring in the course of therapy. This method enables to show biological mechanisms 
of therapeutic alliance or reduction of basic anxiety. In the third category of studies, changes in cerebral 
metabolism that occur due to psychotropic medication and psychotherapy are observed with the aid of 
neuroimaging. Here, the findings are extremely interesting, for instance, in treatment of depression psy-
chotherapy brings about more specific changes than anti-depression drugs. Most of the investigation is 
focused on the effects of psychotherapy for patients suffering from depression and obsessive-compulsive 
disorder because of high homogeneity of these disorders. Schizophrenia-related disorders are less ho-
mogeneous, and owing to that drafting a research plan is a much more complicated task. So the path to-
wards neuroscience, which may account for the effects of psychotherapy, is still unexplored.
schizophrenia / neuroscience / psychotherapy
INTrOdUCTION
Since the early twentieth century, no agree-
ment has been reached among psychiatrists 
nor conclusive scientific evidence has been 
found to corroborate Kraepelin’s hypothesis 
concerning the nosological homogeneity of disor-
ders that, following Bleuler, are termed as “schiz-
ophrenia”. Within the period of almost one hun-
dred years after Bleuler’s publication, a number of 
new approaches and concepts have emerged so as 
to elucidate the nature of the disorder; nowadays, 
under the influence of American psychiatry, the 
majority of psychiatrists use the term introduced 
by Bleuler to refer to the disorder as viewed by 
Kraepelin, who called it dementia praecox.
Despite the discord as to the boundaries, na-
ture, and symptoms adopted as diagnostic cri-
teria, some compromise, however, has been at-
tained. It pertains to the complex pathogenesis 
of the disorder. In the 1960’s it was assumed that 
the disorder is due both to biological and psy-
chosocial factors, the former being responsible 
for the individual proneness to develop the dis-
order, the latter – for the onset. In discussions 
of the origins and dynamics of schizophrenia-
like disorders, the vulnerability-stress hypoth-
esis was applied in order to formulate, among 
others, the theoretical basis of the concept of in-
tegrated treatment or, as Alanen terms it [1], 
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needs-adapted treatment. Its multiple variants 
embrace pharmacotherapy, psychotherapy, fam-
ily therapy, a system of community and social 
services.
As compared to other elements of integrated 
treatment, pharmacotherapy is based on well-re-
searched effects of chemical substances and the-
oretical models of the pathogenesis of the disor-
der. The latter include the hypothesis concerning 
the role of neurotransmitters in schizophrenia 
and the explanation of the effects of medication 
obtained through modulation of neurotrans-
mission. These theories can be operationalised 
and verified via experiments, e.g. checking an-
imal models of the disorder. They also provide 
a starting point for the synthesis of new medi-
cines. Theoretical foundations of the remaining 
elements of integrated treatment are a slightly 
different case. Psychological and sociological 
concepts of the origins of schizophrenic disor-
ders, including the 1970’s anti-psychiatric nega-
tion of their occurrence, attractive as they may 
seem, did not comply with academic discipline, 
which is imperative in contemporary medicine. 
The persuasiveness of scientific arguments and 
unquestionable efficiency of anti-psychotic med-
ication in alleviating the symptoms of schizo-
phrenic disorders made it easier to forget that 
the neurotransmission theory required a limit-
ed, narrow field of observation: selected chemi-
cal substances. Indeed, this model of schizophre-
nia which is based on neurotransmission theory 
brings schizophrenia down to a metabolic dis-
ease of the brain.
According to many schizophrenia research-
ers, this is an excessive reduction as it excludes 
the explanation of cerebral functioning in ill-
ness and good health. Alanen, quoting Fleck, 
was unwilling to perceive human functioning 
as a laboratory flask [1]. The introduction of the 
idea of needs-adapted treatment of schizophre-
nia summed up his long-standing clinical psychi-
atric practice and research as well as knowledge 
of recently implemented organisational changes 
in the treatment of people with schizophrenia-
related diseases. The mentioned changes were 
aimed at the application of a wide spectrum of 
therapeutic methods: from psychoanalytically-
oriented psychotherapy to systemic family thera-
py and community support, with pharmacother-
apy still present. Since long, a comprehensive, in-
tegrated, holistic therapeutic approach seemed to 
be the only sensible solution in the treatment of 
patients with schizophrenia-like disorders. Also 
Kępiński	[2,	3]	gave	similar	treatment	guide-
lines, based on the presupposition that it is pos-
sible to account for human functioning, both in 
illness and good health, within the framework 
of interpersonal relations and functional cere-
bral	structures.	In	the	1960’s	Kępiński	attempt-
ed to create a biological model of mental func-
tions, which he called a model of information 
metabolism.
Alanen,	Kępiński	and	Fleck	could	not	consid-
er the neurotransmission model as adequate be-
cause their psychiatric thinking had solid hu-
manist foundations. The developments of neu-
roscience, from an entirely different perspec-
tive, prove that they were right. The knowledge 
which has accumulated throughout the last dec-
ade makes us abandon the hope that schizophre-
nia-related disorders could be explained by the 
presence of one genetic mutation. Molecular ge-
netics make us realize that the memory matrix 
included in the chemical structure of the gene 
allows for the construction of proteins and func-
tional neuronal connections. But the initiation 
of its activity and the type of this activity both 
depend on the environment. Moreover, it is not 
solely the chemical environment, which provides 
the necessary substrates for the synthesis, but the 
entirety of environmental influences. This was 
confirmed by research on the impact of stress on 
gene expression.
Another significant contribution, which ex-
panded our understanding of the links between 
cerebral functions and environmental impact, is 
the findings of neuroscience on the mother-child 
relation and the development of functional brain 
structures. The research is done mainly on ani-
mals, but also – whenever non-invasive methods 
can be applied – on humans and supplies evi-
dence as to the effect of the mentioned relation 
on neuronal connections between the amygda-
la and pre-frontal cortex [4, 5], as well as on the 
neuro-hormonal efficiency in response to stress. 
These detailed data (which may be also deemed 
fragmentary) support previous research findings 
that pointed to the increased risk of schizophre-
nia among people who were deprived of paren-
tal contact in childhood. As established by Agid 
et al. [6], this risk grew 3.8 times higher when 
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somebody lost a parent before they turned 17, 
and 4.3 times higher when the loss was suffered 
before the age of 9. The importance of these sci-
entific achievements lies in that they bridge the 
gap between the biological and psychological 
approach towards mental disorders and their 
treatment.
Even more interest may be attracted by the in-
terpretation based on research findings by Kan-
del [7] concerning memory. The discovery that 
memory stimulates the expression of genes (as 
influenced by experience, i.e. learning) that are 
responsible for the synthesis of proteins which 
allow neurons to function won him the Nobel 
Prize. Kandel’s reduction was to choose the sim-
plest available animal brain to investigate learn-
ing processes, based on memory. It was the 
brain of a sea snail. The brain of Aplysia, as op-
posed to the brain of humans, is obviously un-
complicated. And of course nobody has stud-
ied schizophrenia in snails. Nevertheless, with 
the use of this model Kandel managed to prove 
that learning entails biological, functional and 
structural changes.
Empirical studies, aiming to account for the 
efficiency of psychotherapy from the neuro-
scientific perspective, are relatively well-ad-
vanced. Generally, they fall into three catego-
ries. (i) Based on the theory of explicit memory 
(declarative memory, consciousness) and implicit 
memory (procedural memory, subconsciousness) 
– which are concepts derived from the findings 
of neuroscience and used for its purposes – the 
mechanisms involved in psychotherapy are be-
ing revised. This method turns out to be useful 
in the investigation of behavioural and cogni-
tive therapy as well as analytical therapy, rely-
ing on interpretations and working-through [8]. 
(ii) Another line of research resorts to function-
al neuroimaging and, experimentally, assesses 
changes in the functions of the brain that occur 
either in a therapeutic setting or due to psycho-
therapy. This allowed to shed light on biologi-
cal mechanisms of interpersonal therapeutic re-
lationship and to prove, for instance, the reduc-
tion of basic anxiety through psychotherapy. (iii) 
In the third category of studies, changes in cer-
ebral metabolism are observed with the help of 
neuroimaging, which occur due to psychotropic 
medication and psychotherapy. Here, the find-
ings are extremely interesting: for instance, in 
treatment of depression, psychotherapy brings 
about more specific changes than anti-depres-
sion drugs [9].
PSyCHOTHErAPy IN TrEATMENT OF  
SCHIZOPHrENIA-dIAGNOSEd PATIENTS
Clinical practice and results of longitudinal 
prospective studies on the course of schizo-
phrenia-related disorders [1] tend to support 
the advantages of integrated treatment, com-
prising psychotherapy. This kind of treatment 
was used based on various theoretical premis-
es, in a number of forms and modalities. And it 
seems none of modern (twentieth-century) psy-
chotherapeutic methods has proclaimed to be in-
efficient.
Those psychotherapeutic techniques have been 
critically evaluated whose application requires 
that patients should be burdened with the stress 
involved in problem-solving, for instance when 
they become aware of an internal conflict and 
work through in psychoanalytical therapy. As 
the vulnerability-stress theory points to the re-
duced ability of coping with stress, it appears 
obvious that during treatment one should avoid 
situations that increase the risk of psychologi-
cal decompensation under stress. Even in psy-
chodynamic therapies, just a few approaches 
permit the aggravation of stress owed to inter-
pretations, but on condition that a thorough pre-
liminary examination is performed. The profun-
dity of intra-psychological conflict, supposedly 
underlying schizophrenia, is – by definition – a 
contraindication to adopt such an approach (e.g. 
short-term anxiety provoking psychotherapy).
The recent years have witnessed a growing 
popularity of these psychotherapeutic activi-
ties that (i) favour the patients’ engagement, 
broaden their knowledge about the illness, 
treatment methods and prevention of relaps-
es, such as psychoeducation; (ii) improve the 
quality of life for the patients and their im-
mediate community, such as family therapy, 
cognitive and behavioural therapy, and long-
term group therapy with various non-specif-
ic modalities (e.g. art).
Regardless of theoretical foundations of a 
particular psychotherapeutic intervention, 
the role of non-specific psychotherapeutic 
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factors is emphasised: emotional support on 
the part on the therapist, a sense of safety 
in individual and group relations, a sense of 
meaningfulness of therapeutic activity.
This is especially conspicuous in the findings 
of the Kraków longitudinal study: the subjec-
tive satisfaction derived from the therapeutic re-
lationship seems to be one of the most impor-
tant predictors for the course of the illness [10]. 
Alanen [1] goes even further in his conclusions 
when searching for indications how to adapt the 
type of psychotherapy to the needs of the pa-
tient and to identify this one that is likely to give 
the patient a sense of safety and support in each 
individual case.
rESEArCH ON THE EFFECTS OF PSyCHOTHErAPy 
IN THE TrEATMENT OF SCHIZOPHrENIA
It is an extremely demanding, if not impos-
sible, task to prepare a standard assessment of 
the effects of psychotherapy in the treatment 
of schizophrenia. The findings of research pro-
grammes that evaluated the efficiency of psy-
chodynamic psychotherapy, even preceding 
pharmacotherapy, were not optimistic. Our own 
study conducted in Kraków, which aimed at the 
assessment of the efficiency of group therapy in 
the treatment of schizophrenia-diagnose adoles-
cents [11] (the therapy being based on the nat-
uralistic method,) showed that in a five-year 
follow-up the therapeutic goal was achieved, 
namely an improvement was observed in the 
subjective need for interpersonal contact. At 
the same time, we did not observe any im-
provement in the skills required to fulfil the 
need. Additionally, the changes were not cor-
related with the further course of the disor-
der. Yet, the findings of this study, as well as 
of other, more sophisticated researched pro-
grammes concerning the efficacy of psycho-
therapy in schizophrenia treatment, as dis-
cussed by Alanen [1], are extremely hard to in-
terpret, primarily because psychotherapy is one 
of the elements of integrated treatment. Anoth-
er programme, run in Kraków [12], aimed at the 
assessment of the efficacy of psychotherapy 
in schizophrenia treatment, provided com-
parisons concerning a random sample of pa-
tients who underwent treatment within dif-
ferent treatment programmes, where the dif-
ference was the proportion of group thera-
py and early rehabilitation. The long-term 
observation led to the conclusion that psy-
chotherapeutic components of the treatment 
programme have a favourable impact on the 
course of the illness if they take into account 
defined individual indications.
These findings were implemented in clin-
ical practice: therapeutic programmes were 
adapted to individual needs. In particular, in 
long-term community programmes [13, 14], 
the following factors were considered: assist-
ance in building the network of social sup-
port, working with the families, rehabilita-
tion efforts to help find employment, sup-
port for social activities. The validity of this 
psychotherapeutic attitude, diversified and 
yet integrated, is corroborated by the benefi-
cial outcomes, as gauged by the quality of life 
[15]. The findings obtained in Kraków belong to 
those that confirm the practicality of psychother-
apy in schizophrenia treatment. Moreover, they 
also support the conviction about the purpose-
fulness of adapting psychotherapeutic activities 
to the needs and capabilities of the person receiv-
ing treatment as well as the belief that psycho-
therapy should be placed within a comprehen-
sive treatment and rehabilitation programme.
Therefore the question that ought to be posed 
now concerns the mechanisms that are responsi-
ble for the therapeutic effect. Depending on the 
basic system of theoretical assumptions for psy-
chotherapy, we can either refer to the psychoan-
alytical idea of the reconstruction of the ego and 
strengthening its defence mechanisms, or to the 
neo-psychoanalytical concept of the reconstruc-
tion of the self and the ability to form a relation 
with the object, or – based on the assumptions of 
the theory of learning – seek the solution in ac-
quisition of socially more efficient behaviours, or, 
lastly, find the possibilities of reducing negative 
emotions in the change of cognitive stereotypes.
Let us illustrate the point by checking wheth-
er and how the ways of coping with difficult sit-
uations change during therapy. The vulnerabil-
ity-stress theory sees psychotherapy as a means 
to modify the ways of coping with stress so that 
they are more efficient.
This study was conducted in day hospital, 
where the psychotherapeutic component em-
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braces everyday community meetings, every-
day group psychotherapy (whose aim is com-
munication and better insight into the illness) as 
well as activities that require non-verbal expres-
sion and improve social competence (e.g. move-
ment therapy, dance, social skills training, psy-
chodrawing and milieu therapy). At the same 
time, each patient remains in individual therapy, 
which is adapted to his/her needs and capabili-
ties. Changes in the repertoire of defence mech-
anisms were assessed with the DSQ 40 [16], pre- 
and post-treatment assessment was conducted, 
and changes in psychopathology were meas-
ured with the PANSS [17]. As expected, the find-
ings showed a statistically significant improve-
ment in the use of mature defence mechanisms 
by the subjects. Besides, it was found that the 
lower level of negative symptoms, according to 
PANSS, and better use of mature defence mecha-
nisms at the beginning of treatment were predic-
tors of more favourable outcomes. On the other 
hand, no correlation was observed between the 
improved use of defence mechanisms and the at-
tenuation of symptoms.
This study has left the authors in a state of con-
fusion about the findings, which is often the case 
in research on treatment outcomes. Better pre-
disposed people have more gains and better out-
comes. But still the question is why ...
There is a possibility that the answer may lie in 
the role of non-specific features of psychothera-
py, and in particular those circumstances that al-
low the patient to find a sense of safety and sup-
port in the therapeutic relationship.
Neuroscience and imaging technology, investi-
gating the functions of the brain, give us hope that 
answers will be found to several vital questions. 
As caused by interpersonal psychotherapy, in de-
pressive patients normalisation changes were ob-
served in the metabolism of the pre-frontal cor-
tex, caudate nucleus and thalamus (decrease), and 
temporal lobe (increase) [18]. In patients with the 
obsessive-compulsive syndrome, lower meta-
bolic activity was observed in the right caudate 
nucleus following behavioural therapy [19]. It 
can be cautiously inferred, on the basis of these 
findings, that psychotherapy impacts the activ-
ity of functional cerebral structures that regu-
late emotions, mainly anxiety. So perhaps it is 
possible to prepare a standard assessment for 
the changes in the distribution and dynamics of 
brain activity in schizophrenia-diagnosed pa-
tients during and after psychotherapy. It seems, 
anyhow, understandable, that hitherto research 
focused on the effects of psychotherapy for pa-
tients suffering from depression and obsessive-
compulsive disorder: schizophrenia-related dis-
orders are less homogeneous, and owing to that 
drafting a research plan is a much more compli-
cated task. And the path towards neuroscience, 
which may account for the effects of psycho-
therapy, is hardly visible yet.
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